Erectile dysfunction is highly prevalent in type II diabetes mellitus.Low intensity extracorporeal shock wave therapy improves erectile function inpatients with erectile dysfunction of vasculogenic origin, including diabetes.However, its mode of […]
Erectile dysfunction is highly prevalent in type II diabetes mellitus.Low intensity extracorporeal shock wave therapy improves erectile function inpatients with erectile dysfunction of vasculogenic origin, including diabetes.However, its mode of […]
A review of preclinical studies – Low-intensity extracorporeal shock wave therapy (LI-ESWT) is a novel treatment for erectile dysfunction (ED). Its ability to improve erectile function has been shown in patients […]
Introduction—Low-energy shockwave therapy (LESWT) has been shown to improve erectile function in patients suffering from diabetes mellitus (DM)-associated erectile dysfunction (ED). However, the underlying mechanism remains unknown. Click here to […]
American Urological Association 2017 – American Urological Association. Dr. Tom Lue addressing erectile dysfunction during debate. Click here to read more.
Cleveland Clinic Daniel Shoskes, MD – As urologists, we have decades of experience with extracorporeal shockwave lithotripsy for breaking apart stones within the body. Today, a related and emerging technology, low-intensity shockwave therapy […]
Urological Times – It’s hard to argue against an erectile dysfunction treatment that is potentially disease modifying, is noninvasive, and seems to do no harm. The treatment, low-intensity shock wave […]
MTS Science Published on Jun 21, 2016 – The improvement of Erectile Dysfunction through the use UroGold has been shown in scientific studies as Spark Waves® promote the generation of new blood […]
PRESS RELEASE PR Newswire 2018 – Comprehensive Urology Medical Group, one of the nation’s leading urological practices, announces the addition of a new low intensity shockwave therapy device (LISWT), PulseWave, […]
Tissue Regeneration Technologies – A four patient pilot trial was conducted in 2018 including four (4) subjects with an average age of 62 (range 57 – 71). All subjects reported […]
National Institutes of Health (Xin Zhang, James D. Krier, Carolina Amador Carrascal, James F. Greenleaf, Behzad Ebrahimi, Ahmad F. Hedayat, Stephen C. Textor, Amir Lerman, and Lilach O. Lerman 2016) – Microvascular […]
